Shuai Wang

Energizer
DISC Type : I

Director Biostatistics at Pfizer

Boston, Massachusetts, United States

Overview

Shuai Wang is a Director of Biostatistics at Pfizer, specializing in late-phase clinical trials for metabolic and cardiovascular agents. A Ph. D. graduate from Boston University, she was a key team member in the successful regulatory approval of the SGLT2 inhibitor, STEGLATRO, and has extensive experience with FDA and EMA interactions.

She was a Williams Award Finalist during her pre-doctoral studies, an honor given to only two students selected for oral presentation from over 150 abstracts.

Personality Overview

Big Picture Person

Enthusiastic

Relationship Oriented

They are naturally enthusiastic, so take their promise with a pinch of salt.  They are people oriented, friendly and like creating new connections. They excel at seeing the bigger picture, and the long-term impact of their decisions.

Topics They Care About

Late-Stage Trials
Leads the statistical design and execution for pivotal Phase IIb and Phase III clinical trials for metabolic and cardiovascular drugs at Pfizer.
Cardiovascular Outcomes
Designs and executes large cardiovascular outcome trials (CVOT), particularly for type 2 diabetes and lipid-lowering agents.
Drug Approval Strategy
Experienced in navigating regulatory interactions with the FDA and EMA, contributing to the successful approval of new therapeutics like the SGLT2 inhibitor STEGLATRO.

Media Appearances

Shuai has no verified media appearances

Work History

10-2022
Director Biostatistics at Pfizer
6-2021 - 10-2022
Director Biostatistics at Cerevel Therapeutics
6-2015 - 5-2021
Associate Director Biostatistics at Pfizer
5-2014 - 8-2014
Summer Intern at AstraZeneca
9-2012 - 5-2015
Research Assistant at Framingham Heart Study, BUSPH

Education

2011 - 2015
Doctor of Philosophy (Ph.D.) from Boston University
2009 - 2011
Master from University of Virginia

More Information

Social Presence :

Prographics :

Exp : 14 Location : Boston, Massachusetts, United States Job Level : Mid-senior Designation : Director Biostatistics at Pfizer
URL has been copied!

Insights For Selling To Shuai

During A Call Or A Meeting

DO's

  • Be friendly and entertaining in your conversation
  • Talk about their team and how your product will help them do things better and easier
  • Speak enthusiastically with energy, maintain a clear and confident tone

DONT's

  • Avoid overloading them with too much detail
  • Avoid cutting into their flow
  • Don’t be excessively objective, be a storyteller

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Shuai is

  • Relationship and trust can be vital with them, sometimes more than anything else.
  • Will you ever get a clear answer from Shuai

  • They are unlikely to say no directly, you have to make that decision yourself.

Insights For Deal Planning

    How fast (or slow) will Shuai move?

  • They are not the fastest decision makers, their friendly approach can give false positive signals.
  • Can Shuai take some risk or not?

  • They may take certain risks that they deem unlikely of personal repercussions.

You And Shuai

Personality Compatibility


Other Pfizer Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.